KBC Group’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41K Hold
2,349
﹤0.01% 1765
2026
Q1
$39K Hold
2,349
﹤0.01% 1731
2025
Q4
$67K Hold
2,349
﹤0.01% 1522
2025
Q3
$69K Hold
2,349
﹤0.01% 1496
2025
Q2
$68K Sell
2,349
-1,088
-32% -$32.2K ﹤0.01% 1448
2025
Q1
$120K Hold
3,437
﹤0.01% 1377
2024
Q4
$153K Buy
3,437
+1,895
+123% +$77.5K ﹤0.01% 1293
2024
Q3
$70K Hold
1,542
﹤0.01% 1524
2024
Q2
$51K Buy
1,542
+460
+43% +$18.8K ﹤0.01% 1603
2024
Q1
$52K Hold
1,082
﹤0.01% 1540
2023
Q4
$80K Buy
1,082
+230
+27% +$15.6K ﹤0.01% 1204
2023
Q3
$62K Buy
+852
New +$68K ﹤0.01% 1291

Other funds holding QDEL

KBC Group's QDEL Position: Q2 2026 in Review

KBC Group held its QuidelOrtho (QDEL) position steady in Q2 2026 at 2,349 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

KBC Group first reported a position in QDEL in Q3 2023 and has held it in 12 quarters since. The position peaked at $153K in Q4 2024. 96 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • KBC Group held 2,349 shares of QuidelOrtho worth $41K as of Q2 2026.
  • KBC Group left its QuidelOrtho share count unchanged in Q2 2026.
  • QuidelOrtho made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1765 holding.
  • KBC Group first reported a position in QuidelOrtho in Q3 2023 and has held it in 12 quarters since.
  • KBC Group's QuidelOrtho position peaked at $153K in Q4 2024.
  • 96 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.